Ohara M et al. |
Myasthenia Gravis Complicated with Peripheral T-cell Lymphoma, Not Otherwise Specified (PTCL-NOS), Following Thymectomy and Longstanding Tacrolimus Therapy. |
2018 |
Intern. Med. |
pmid:29269644
|
Felipe C et al. |
Adequacy of Initial Everolimus Dose, With and Without Calcineurin Inhibitors, in Kidney Transplant Recipients. |
2018 |
Ther Drug Monit |
pmid:29271815
|
Kimura Y et al. |
Profiling the immunotoxicity of chemicals based on in vitro evaluation by a combination of the Multi-ImmunoTox assay and the IL-8 Luc assay. |
2018 |
Arch. Toxicol. |
pmid:29594315
|
Loeschenberger B et al. |
Calcineurin inhibitor-induced complement system activation via ERK1/2 signalling is inhibited by SOCS-3 in human renal tubule cells. |
2018 |
Eur. J. Immunol. |
pmid:29143318
|
Özçakar ZB et al. |
Transplantation within the era of anti-IL-1 therapy: case series of five patients with familial Mediterranean fever-related amyloidosis. |
2018 |
Transpl. Int. |
pmid:29957882
|
Tang JT et al. |
A Low Fixed Tacrolimus Starting Dose Is Effective and Safe in Chinese Renal Transplantation Recipients. |
2018 |
Ann. Transplant. |
pmid:29735966
|
Cai W et al. |
Limited Sampling Strategy for Estimating Mycophenolic Acid Exposure on Day 7 Post-Transplant for Two Mycophenolate Mofetil Formulations Derived From 20 Chinese Renal Transplant Recipients. |
2018 |
Transplant. Proc. |
pmid:29735215
|
Zhang Y and Zhang R |
Recent advances in analytical methods for the therapeutic drug monitoring of immunosuppressive drugs. |
2018 |
Drug Test Anal |
pmid:28851030
|
Riva N et al. |
Survival Time to Biopsy-Proven Acute Rejection and Tacrolimus Adverse Drug Reactions in Pediatric Liver Transplantation. |
2018 |
Ther Drug Monit |
pmid:29621122
|
Choi CB et al. |
Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis. |
2018 |
Lupus |
pmid:29448881
|